Curve Bg

Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immune (I&I) diseases with high unmet need.

Close-up of photo of an infant showing the bottom half of the face with atopic dermatis rash

Refusing to stop at Left Quotegood enoughRight Quote

Apogee is seeking to reshape the current standard of care for inflammatory and immune diseases because we believe people living with these diseases deserve the best possible treatment.

Our pipeline of differentiated antibody therapeutics targets well-established biological drivers and development pathways, with an initial focus on making impactful advancements in the treatment of atopic dermatitis and chronic obstructive pulmonary disease.

Photograph looking through a glass window into a conference room with Apogee team members sitting around a table

Our Team

Our seasoned team of skilled drug developers and operators are driven by the desire to give better treatment options to people living with inflammatory and immune diseases.

People first, always


We strongly believe the best thing we can do for fellow teammates and people living with inflammatory and immune diseases is to create an environment of psychological safety, where everyone feels comfortable sharing different ideas and ultimately coming to the best answer together.